URSOFALK susp fl 250 ml
7680546340216
CH-54634
A05AA02
04.99.0.
Reimbursement limitations:
DEURSIL
Pour les calculs de Cholésterol et la cirrhose biliaire primitive (CBP).
1 / 3
google
Details
- Product number
- 5463401
- CPT
- -
- Packaging group
- 250
- Unit
- ml
- Composition
- acidum ursodeoxycholicum 250 mg, aqua purificata, xylitolum, glycerolum, cellulosum microcristallinum et carmellosum natricum, propylenglycolum 50 mg, natrii citras dihydricus, acidum citricum, natrii chloridum, natrii cyclamas, aromatica (Lemon), E 210 7.5 mg ad suspensionem pro 5 ml corresp. natrium 11.1 mg.
Articles (1)
Ursofalk, Suspension
suspension
250
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
50.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
7.5 MG | Substance | HBESI |
|
(N/A)
|
11.1 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 53.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1999
Authorization holder
Dr. Falk Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 54634
- Drug name
- Ursofalk, Suspension
- Galenic form
- SUOR
- ATC Code
- A05AA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/11/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 04.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- URSOFALK susp fl 250 ml
- Description (DE)
- URSOFALK Susp Fl 250 ml
- Market launch
- 30/11/1998
- Narcotic (BTM)
- No